Correction: The Role of Islet Autoantibodies in Gestational Diabetes and Their Association with Postpartum Diabetes Risk: A Systematic Review and Meta-Analysis

By
Frontiers Production Office
August 24, 2026

Frontiers In Endocrinology

Background

Gestational diabetes mellitus (GDM) is a significant complication during pregnancy. Understanding the role of islet autoantibodies in GDM is crucial for identifying women at risk for developing T2DM.

Data Highlights

No numerical data or trial data is presented in the correction article.

Key Findings

Errors in figure assignments and captions were identified and corrected.
Figure 1's caption was missing copyright citation and labels.
Figures 2, 3, and 4 had incorrect images and captions assigned.
The original article has been updated to include corrected figures.

Clinical Implications

Accurate representation of data and figures in clinical publications is essential for proper interpretation and application in practice. Clinicians should refer to the updated article for reliable information regarding islet autoantibodies in GDM.

Conclusion

The correction ensures that the findings related to islet autoantibodies in gestational diabetes are accurately presented, which is vital for ongoing research and clinical understanding.